Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sony Tuteja

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|July 22, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy DosingLisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2020
Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 18, 2020
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Clinical and Translational Science|June 10, 2022
Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19Sony Tuteja, Zhihong Yu, Otis Wilson, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersAkinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, et al.
JCO Precision Oncology|August 7, 2025
Implementation of <i>DPYD</i> and <i>UGT1A1</i> Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical TrialSony Tuteja, Mari Angelica S Cayabyab, Glenda Hoffecker, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
<i>CYP2C19</i> Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans ProgramCatherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.
Clinical Pharmacology and Therapeutics|June 3, 2025
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran ProgramCatherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2022
Impact of integrating genomic data into the electronic health record on genetics care deliveryKelsey S Lau-Min, Danielle McKenna, Stephanie Byers Asher, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|July 22, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy DosingLisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2020
Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 18, 2020
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Clinical and Translational Science|June 10, 2022
Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19Sony Tuteja, Zhihong Yu, Otis Wilson, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersAkinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, et al.
JCO Precision Oncology|August 7, 2025
Implementation of <i>DPYD</i> and <i>UGT1A1</i> Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical TrialSony Tuteja, Mari Angelica S Cayabyab, Glenda Hoffecker, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
<i>CYP2C19</i> Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans ProgramCatherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.
Clinical Pharmacology and Therapeutics|June 3, 2025
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran ProgramCatherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2022
Impact of integrating genomic data into the electronic health record on genetics care deliveryKelsey S Lau-Min, Danielle McKenna, Stephanie Byers Asher, et al.
Pageof 9